Gallo to Establish a Major AIDS Institute
BETHESDA, Md--One of the discoverers of HIV, Robert C. Gallo, MD, is leaving the National Cancer Institute after 30 years, most recently as head of the Division of Tumor Cell Biology.
BETHESDA, Md--One of the discoverers of HIV, Robert C. Gallo,MD, is leaving the National Cancer Institute after 30 years, mostrecently as head of the Division of Tumor Cell Biology.
He will establish a major AIDS research institute at the Universityof Maryland, Baltimore, to be called the Institute of Human Virology.The institute will be supported by at least $9 million in Marylandtax revenues for the first 3 years and will receive an additional$3 million in Baltimore city funds, Dr. Gallo said.
It eventually will employ 250 people and have an annual budgetof $25 million to $30 million, including government grants andcollaboration with private industry.
Two top scientists accompanying Dr. Gallo to Baltimore are WilliamBlattner, MD, chief of the NCI's Viral Epidemiology Branch, andRobert Redfield, MD, a clinical virologist at the Walter ReedArmy Institute of Research.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
![“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2F267879fc15a40ec8d3ed04d8ee9c1f044b49ee89-2990x1692.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 "“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.")
